Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion type Assertion NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_head.
- NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion description "[The progress of the orexin field is thus extraordinary, and the community awaits the clinical testing of more receptor selective antagonists in sleep and other disorders, as well as that of orexin agonists, with the latter expected to produce positive outcomes in narcolepsy/cataplexy and other conditions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_provenance.
- NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion evidence source_evidence_literature NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_provenance.
- NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion SIO_000772 24215799 NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_provenance.
- NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion wasDerivedFrom befree-2016 NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_provenance.
- NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_assertion wasGeneratedBy ECO_0000203 NP1126913.RAhN7t5u6cXkoJCJM8cYHno1gGei9MXkrbacM9X6wKCFg130_provenance.